STOCKWATCH
·
Pharmaceuticals
Shareholding10 Dec 2024, 10:24 pm

Biocon Ltd. Sells 80 Lacs Shares of Syngene International Limited for ~686 Crores

AI Summary

Biocon Ltd. has sold 80,00,000 equity shares of Syngene International Limited in the open market through a block deal mechanism on December 10, 2024. This transaction has resulted in Biocon's shareholding in Syngene reducing to 52.46%. The sale was made for a gross traded value of approximately ~686 Crores on the exchange, subject to statutory levies, brokerage, etc. None of the buyers belonged to the promoter/promoter group or group companies. The sale was not a related party transaction and was not part of a Scheme of Arrangement.

Key Highlights

  • Biocon sold 80,00,000 equity shares of Syngene International Limited
  • The transaction was worth approximately ~686 Crores
  • Post-transaction, Biocon's shareholding in Syngene stands at 52.46%
  • No buyers belonged to the promoter/promoter group or group companies
  • The sale was not a related party transaction and was not part of a Scheme of Arrangement
BIOCON
Pharmaceuticals
BIOCON LTD.

Price Impact